IMPEDIMED LIMITED — Director's Dealing 2020

Jul 5, 2020

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: ImpediMed Limited ABN: 089 705 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Robert Graham
Date of last notice	04 May 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstancesgiving rise to the relevant interest.	RM Graham Pty LtdAstrusteeforR&JGrahamFamilySuperannuation FundDr Graham is a director of RM Graham PtyLtd and a beneficiary of the SuperannuationFund.
Date of change	01 July 2020
No. of securities held prior to change	Direct:269,684 OptionsIndirect:773,186 Ordinary shares
Class	Ordinary shares
Number acquired	Direct:191,761 Ordinary shares

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

	ppendix 3Yhange of Director’s Interest Notice	ppendix 3Yhange of Director’s Interest Notice	ppendix 3Yhange of Director’s Interest Notice
	Number disposed		Ni	l
	Value/Considerationote If consideration is non-cash rovide		$0	.066 per share
	: , pdetails and estimated valuation
No. of securities held after change	No. of securities held after change		Di1926In7	rect:1,761 Ordinary shares9,684 Options
				direct:3186 Odi h
			, rnary sares
Nature of changeExample: on-market trade, off-market trade,exercise of options, issue of securities underdividend reinvestment plan, participation inbuy-back			Issue of shares in lieu of director fees for
		xample: on-market trade, off-market trade,xercise of options, issue of securities underividend reinvestment plan, participation inuy-back	quarter ended 30 June 2		020.
		rt 2 – Change of director’s interests in contracts

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?
If prior written clearance was provided, on what date wasthis provided?

Date of Notice: 06 July 2020

• See chapter 19 for defined terms.

Appendix 3Y Page 2